Multi-institutional analysis reveals comparable survival with cardiopulmonary bypass in advanced vena cava thrombectomy, suggesting surgical approach does not dictate mortality risk.
In our multi-institutional analysis the use of cardiopulmonary bypass did not significantly impact cancer specific survival or overall survival in patients undergoing nephrectomy and level III or IV tumor thrombectomy. Neither approach was independently associated with increased mortality on multivariate analysis. Greater surgical complications were not independently associated with the use of cardiopulmonary bypass.
No takes yet. Share an insight, caveat, or question.
Nguyen et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: